Optimal blood pressure for patients with chronic kidney disease: a nationwide population-based cohort study

You-Bin Lee1,2, Ji Sung Lee3, So-Hyeon Hong1

  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul, 08308, Republic of Korea.

Scientific Reports
|January 16, 2021
PubMed

Insights

High blood pressure (BP) increases cardiovascular events and mortality in chronic kidney disease (CKD) patients. Optimal BP targets are crucial; avoid SBP <100 mmHg with antihypertensives to prevent adverse outcomes.

Area of Science:

  • Nephrology and Cardiovascular Medicine
  • Hypertension Management in Chronic Kidney Disease (CKD)

Background:

  • Chronic kidney disease (CKD) patients face elevated risks of cardiovascular events, end-stage renal disease (ESRD), and mortality.
  • The impact of blood pressure (BP) management on these adverse outcomes in CKD, particularly with antihypertensive treatment, requires precise understanding.

Purpose of the Study:

  • To evaluate the association between blood pressure levels and the risk of incident cardiovascular events, ESRD, and mortality in CKD patients.
  • To assess these risks in both treated and untreated CKD patients, identifying optimal BP targets for antihypertensive therapy.

Main Methods:

  • Nationwide cohort study utilizing Korean National Health Insurance Service-Health Screening Cohort data.
  • Analysis of 22,278 adults (≥40 years) with CKD, excluding those with prior cardiovascular disease or ESRD.
  • Hazard ratios for adverse outcomes were analyzed based on systolic BP (SBP) and diastolic BP (DBP) categories, with and without antihypertensive treatment.

Main Results:

  • Elevated SBP (≥130 mmHg) and DBP (≥80 mmHg) were linked to higher risks of adverse outcomes compared to reference BP ranges (SBP 120-129 mmHg, DBP 70-79 mmHg).
  • SBP <100 mmHg was associated with increased all-cause mortality and a composite of ESRD and all-cause mortality, specifically among antihypertensive medication users.
  • A significant proportion of CKD patients had BP levels ≥130/80 mmHg (48.52% SBP, 51.99% DBP).

Conclusions:

  • Maintaining BP <130/80 mmHg is recommended for CKD patients to mitigate hypertension-related risks.
  • For patients on antihypertensive agents, systolic BP should not fall below 100 mmHg to avoid risks associated with undertreatment.
  • These findings highlight the importance of tailored BP targets in CKD management to prevent adverse outcomes from both insufficient and excessive treatment.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
206
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
356
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
152
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
212
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
81